Manufacturers know that evidence is currency in payer negotiations. Fragmented datasets only tell a partial story that leaves payers skeptical.
That’s why linked datasets have become the gold standard for health economics and outcomes research (HEOR). EMRClaims+ from eMAX Health unites the clinical and administrative sides of care, creating a clear, defensible view of value that’s both timely and verifiable.
Why Linking EMR + Claims Matters
Real-world data often falls short in one of two ways: it’s either clinically rich but limited in scale (EMR-only) or broad but shallow (claims-only).
By connecting the two, EMRClaims+Â enables analyses that show what happened, why it happened, and what that means for outcomes, adherence, and cost offsets.
Linked data unlocks:
- True longitudinal follow-up across inpatient, outpatient, and pharmacy settings
- Complete clinical context, from lab values to medication orders
- Timely visibility—records updated within 30 days of extract
- Representative populations across millions of covered lives
This combination helps HEOR teams demonstrate value with confidence and gives payers the transparency they increasingly demand.
From Evidence to Advantage
When payers evaluate coverage, they ask three questions:
- Does the data reflect real practice?
- Is the effect measurable and durable?
- Can we justify reimbursement based on total cost of care?
EMRClaims+ data lets manufacturers answer “yes” to all three.
Our analysts and biostatisticians integrate clinical detail with utilization patterns to quantify not just efficacy, but efficiency, to show how therapy choice impacts readmissions, resource use, and downstream costs. That’s the kind of evidence that turns value arguments into value proof.
Application in HEOR and Beyond
Linked EMR + claims data supports:
- Cost-effectiveness and budget-impact modeling
- Comparative-effectiveness and outcomes studies
- Patient journey mapping and predictive risk modeling
- Validation of assumptions for value-based contracting
In short, it’s not just data—it’s negotiation leverage.
With EMRClaims+, you can bridge the evidence gap between clinical promise and real-world performance—arming your HEOR and market-access teams with data that persuades, not just informs.
Ready to strengthen your value story?
Connect with our team at info@emaxhealth.net to learn more